Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
Inv. presentation
CADENCE PHARMACEUTICALS INC (CADX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2014 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results"
11/05/2013 8-K Form 8-K - Current report
07/31/2013 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results"
05/02/2013 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results"
03/07/2013 8-K Form 8-K - Current report
11/05/2012 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results"
08/02/2012 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results — Strong Revenue Growth Continues"
05/03/2012 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results"
11/03/2011 8-K Form 8-K - Current report
08/03/2011 8-K Form 8-K - Current report
05/05/2011 8-K Form 8-K - Current report
11/05/2010 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results —Prepares for Launch of OFIRMEV™ Injection"
08/05/2010 8-K Form 8-K - Current report
05/06/2010 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports First Quarter 2010 Financial Results"
03/15/2010 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results"
11/05/2009 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results"
08/05/2009 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results"
05/07/2009 8-K Form 8-K -- Current report
03/12/2009 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Financial Results and Provides Corporate and Clinical Updates Acetavance™ On Track for Second Quarter 2009 NDA Submission; Omigard™ Program Discontinued"
11/06/2008 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update"
08/07/2008 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Second Quarter 2008 Financial Results and Provides Overview of Clinical Programs"
05/06/2008 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update Phase III Clinical Trial of Acetavance™ for the Treatment of Fever Achieves Primary Endpoint Phase III Clinical Trial of Omigard™ Completes Patient Enrollment"
11/14/2007 8-K Quarterly results
Docs: "CADENCE PHARMACEUTICALS REPORTS THIRD QUARTER 2007"
08/14/2007 8-K Quarterly results
Docs: "CADENCE PHARMACEUTICALS REPORTS SECOND QUARTER 2007 FINANCIAL RESULTS"
05/14/2007 8-K Quarterly results
Docs: "CADENCE PHARMACEUTICALS REPORTS FIRST QUARTER 2007 FINANCIAL RESULTS AND DEVELOPMENT HIGHLIGHTS"
03/13/2007 8-K Quarterly results
Docs: "Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Financial Results SAN DIEGO, CA — March 13, 2007 — Cadence Pharmaceuticals, Inc. , a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today financial results for the fourth quarter and year ended December 31, 2006. For the fourth quarter ended December 31, 2006, Cadence reported a net loss of $9.0 million, or $0.53 per share, compared to a net loss of $2.1 million, or $1.74 per share, for the same period in 2005. For the year ended December 31, 2006, Cadence reported a net loss of $52.2 million, or $10.07 per share, as compared to a net loss of $7.7 million, or $6.67 per share, for the same period in 2005. T..."
12/01/2006 8-K Quarterly results
Docs: "CADENCE PHARMACEUTICALS REPORTS THIRD QUARTER 2006 FINANCIAL RESULTS AND DEVELOPMENT HIGHLIGHTS"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy